In a paper published in Cell, UNC School of Medicine researchers led by Bryan Roth, MD, PhD, show how to activate only one kind of brain receptor vital for pain relief. This receptor is not involved in addiction or respiratory depression that leads to death – the most severe side effects of opioid use.
For the first time, scientists at the University of North Carolina School of Medicine and collaborators solved the crystal structure of the activated kappa opioid receptor bound to a morphine derivative. They then created a new drug-like compound that activates only that receptor, a key step in the development of better pain medications.
The research, published in the journal Cell, shows a route toward creating opioids that relieve pain without causing the severe side effects at the heart of the opioid epidemic.
Currently, most opioids bind to several opioid receptors on the surface of cells, and this is one of the main reasons why opioids relieve severe pain but also trigger a wide range of side effects from nausea, numbness, and constipation to anxiety, severe dependency, hallucinations, and even death caused by respiratory depression.
“To create better opioids, we need to know the structure of their receptors,” said senior author Bryan Roth, MD, PhD, the Michael Hooker Distinguished Professor of Protein Therapeutics and Translational Proteomics in the Department of Pharmacology at UNC-Chapel Hill. “Until recently, this was impossible. But now we know the structure of the activated kappa opioid receptor. And we showed we can actually use the structure to make a drug-like compound with better properties than current opioids.”
The work was done in cell cultures in Roth’s lab, and in the future researchers will test this and related compounds in animal models. Also, using the detailed structure of the kappa opioid receptor (KOR), Roth’s lab and other scientists could develop other drug-like compounds highly selective for specific opioid receptors now that the structure is available.
“Tens of thousands people who take opioids die every year, and so we need safer and more effective drugs for treating pain and related conditions,” Roth said. “One of the big ideas is to target KORs because the few drugs that bind to it don’t lead to addiction or cause death due to overdose. Those side effects are mainly related to actions at the mu opioid receptor.”
Drugs that do hit KORs can have other side effects, such as hallucinations and dysphoria – a general state of unease or dissatisfaction with life related to anxiety and depression. This is why scientists need to know how this receptor is activated – to figure out the best way to bind a compound to KORs to only relieve pain.
Two postdoctoral fellows in Roth’s lab led the work – first author Tao Che, PhD, and corresponding author Daniel Wacker, PhD, who collaborated with several other scientists at UNC and around the world.
Receptors are proteins on the surface of cells. About 40 percent of drugs currently on the market target G-protein coupled receptors, or GPCRs, such as KORs. Typically, scientists have solved the chemical structure of proteins using a technique called x-ray crystallography. They first figure out the best way to force the protein to condense into a tightly packed crystal lattice, then shoot x-rays at the crystal, and finally calculate the protein’s structure based on how the x-ray beams change direction. But it’s very difficult to do this with opioid receptors because they are so small and delicate, and they do not sit still when bound to a ligand, or drug-like compound. And the exact moment a scientist would want to see the structure of the activated receptor is when it is bound to a compound that will then cause a biological effect, like a key opening a door.
To overcome this difficulty, Wacker, Che, and colleagues used Lipidic Cubic Phase crystallization – suspending KOR molecules in specially designed water-lipid mixtures and then slowly removing the water. Then, in order to be sure the receptors were sitting perfectly still, the researchers employed a variety of experimental tricks, including the use of a tiny antibody to “prop up” the receptor in its active state bound to a ligand – a derivative of morphine created by Sush Majumder, PhD, at Memorial Sloan Kettering Cancer Center. Che figured out this derivative called MP1104 would work after he screened dozens of similar candidates from the same class of drugs.
Once they had the crystal structure in hand, Che, Wacker and colleagues could see which parts of the receptor were important for binding to drug-like compounds. Collaborators at the University of Southern California led by Vsevolod Katritch, PhD, used computer models of ligands to see which parts they could chemically modify to make the ligands more likely to bind tightly to KORs but not to other receptors. With those modifications made, they synthesized a new compound and showed in lab tests that it is extremely selective for KORs.
“Now we have a much better understanding of the direction we have to explore in order to create a selective drug to activate only kappa opioid receptors,” Wacker said.
Che added, “It’s now possible to design new drugs based on the findings on this active KOR structure and tweak them to only have the desired pain relief effects.”
The Latest on: Opioids
- Chronic pain patients need services beyond just opioids: B.C. advocate on January 15, 2018 at 1:17 am
VANCOUVER — People who live with chronic pain need options beyond prescription opioids, and it's up to the British Columbia government to provide more services such as physiotherapy, says the head of a group that supports patients and their families. […]
- Michigan Announces Tool to Aid in Opioids Fight on January 15, 2018 at 12:28 am
The new Michigan Automated Prescription System (MAPS) is now equipped with Appriss Health's NarxCare, a data analysis solution to improve patient care and also fight the opioid epidemic in the state. Michigan's Department of Licensing and Regulatory ... […]
- New County Sheriff Vows To Crack Down On Gangs, Opioids on January 14, 2018 at 4:51 pm
SUFFOLK COUNTY — New Suffolk County Sheriff Errol D. Toulon Jr. was sworn in to office Friday — and he gave a moving and powerful inaugural speech at the Suffolk County Community College campus in Brentwood, vowing to crack down on gangs and opioids. […]
- Christie's top lawyer survived Bridgegate, fought opioids and is now talking about it on January 14, 2018 at 2:52 pm
Christopher Porrino was five days from starting his new job as chief counsel to the governor of New Jersey in January 2014 when the call came telling him he'd have to start early. "I was asked if I could be up at Drumthwacket by noon," Porrino said ... […]
- Opioids, wildfires, PTSD among Florida Cabinet priorities on January 14, 2018 at 11:15 am
TALLAHASSEE, Fla. (AP) — Attorney General Pam Bondi wants new laws to protect people who report sexual misconduct; Agriculture Commissioner Adam Putnam wants to make sure the state is prepared for a higher-than-normal risk for wildfires; and Chief ... […]
- Ohio imposes strict rule on workers' back surgery, opioids on January 14, 2018 at 3:12 am
COLUMBUS, Ohio — Ohio residents with work-related back injuries in most cases must try remedies like rest, physical therapy and chiropractic care before turning to spinal fusion surgery and prescription painkillers under a groundbreaking new guideline ... […]
- VA hospital first to disclose how many opioids it prescribes on January 13, 2018 at 8:12 pm
SALT LAKE CITY, Utah (KUTV)- Veterans Affairs took an unprecedented move in its fight against the opioid epidemic. It's the first hospital to tell the public how many opioids it prescribes to patients. VA officials in Salt Lake City said knowledge is power ... […]
- North Coventry students illustrate dangers of opioids on January 13, 2018 at 8:01 pm
A young girl was digging through the kitchen cabinets looking for drugs in her friend's house when she discovered a bottle of expired oxycodone. The girl then ingested the pain pills in a bathroom. Moments later, she was passed out on the floor. That was a ... […]
- Though still sometimes needed, opioids no longer go-to solution for patients' pain on January 12, 2018 at 10:07 pm
Local physicians are doing their part to turn the tide of the opioid epidemic. Opioids, opium-like compounds that bind to one or more of three opioid receptors in the human body, are often prescribed to help people deal with severe pain from injury or surgery. […]
- Tamper-proof opioids won’t stop epidemics on January 12, 2018 at 7:16 pm
Tamper-resistant or “abuse-deterrent” opioids have been held up by the pharmaceutical industry, government health agencies, state lawmakers, and health professionals as a potential solution to the opioid epidemic growing in the US. The problem is there ... […]
via Google News and Bing News